- Open Access
Anthropometric measures and the risk of developing atrial fibrillation: a Swedish Cohort Study
BMC Cardiovascular Disorders volume 21, Article number: 602 (2021)
Obesity is a risk factor for several cardiovascular diseases (CVDs), including atrial fibrillation (AF). However, it is less clear whether overall fat or abdominal fat distribution are most important for risk of developing AF. This study investigates how different anthropometric measures correlate to the risk of developing clinical AF in the Malmö Diet and Cancer cohort (MDC-cohort).
The MDC-cohort (n = 25,961) was examined in 1991–1996. The endpoint was clinical AF diagnosed in a hospital setting, and retrieved via linkage with national registers. Hazard Ratios (HR) for incident AF was calculated in relation to quartiles of body mass index (BMI), waist circumference, waist hip ratio, waist height ratio, body fat percentage, weight and height, using Cox regression with adjustment for age, biological (e.g. blood pressure, diabetes, blood lipid levels), and socioeconomic risk factors.
After adjustment for multiple risk factors, the risk of AF was significantly increased in the 4th versus 1st quartile of weight (HR for men/women = 2.02/1.93), BMI (HR = 1.62/1.52), waist circumference (HR = 1.67/1.63), waist to hip ratio (HR = 1.30/1.24), waist to height ratio (1.37/1.39) and body fat percentage (HR = 1.21/1.45) in men/women. Measures of overall weight (BMI, weight) were slightly more predictive than measures of abdominal obesity (waist hip ratio and waist height ratio) both in men and women.
All measures of obesity were associated with increased risk of developing AF. Both overall obesity and abdominal obesity were related to incidence of AF in this population-based study, although the relationship for overall obesity was stronger.
Obesity is an established risk factor for several cardiovascular diseases (CVDs) [1,2,3,4], including increased incidence of atrial fibrillation (AF) [5,6,7,8]. Obese individuals have a 50% increased risk of developing AF  and it has been estimated that a one-unit increase of mean BMI in the population could result in 6–8% more patients with AF . Considering that the prevalence of obesity is increasing [10, 11], it is likely that prevalence of obesity-related AF will increase as well .
Obesity increases total blood volume, which causes structural changes to the heart, such as left and right ventricular hypertrophy [13,14,15]. Additionally, it leads to increased epi- and pericardial adipose tissue , which is associated with higher AF recurrence rate after ablation and higher burden of symptoms in patients with AF . These structural changes alter cardiac electrical circuits, which could increase the risk of AF [13,14,15,16].
Fat distribution is of importance in the risk assessment for several cardiometabolic diseases, and it is widely accepted that the prognostic significance of increased intra-abdominal fat, such as increased waist circumference (WC) or waist to height ratio (WHtR), is more disadvantageous than increased subcutaneous fat [11, 17,18,19]. However, the role of abdominal fat distribution is less clear with respect to incidence of AF. Measures of overall obesity (i.e. body mass index (BMI), body fat percentage (BF %) and weight) and abdominal obesity (i.e. WC, waist to hip ratio (WHR) and WHtR) have both been shown to correlate positively with the risk of developing AF [4, 5, 8, 9, 12, 20, 21]. This raises the question if the role of intra-abdominal fat distribution is similar for AF as compared to other cardiometabolic diseases.
The purpose of this study was to investigate the relationship between different anthropometric measures (BMI, weight, height, WC; WHR, WHtR and BF %) and incidence of AF in a population-based cohort study, to further investigate the relationship between fat distribution and AF in a large population-based cohort study with long follow-up.
Data from the “Malmö Diet and Cancer (MDC)”  cohort was used. In this cohort, all men born between 1923 and 1945 and all women born between 1923 and 1950, living in the city of Malmö were invited to participate in a screening examination between 1991 and 1996. A total of 30,446 subjects participated; participation rate was approximately 41%. After exclusion of individuals with history of AF at baseline (n = 312), missing anthropometric measures, missing biological or life-style co-variables or missing follow-up (n = 4173), a total of 25,961 individuals (9883 men; 16,078 women) were included in the study population. Mean BMI in the excluded group was 26.6 kg/m2 and mean age was 59.6 years. The cumulative incidence rate of AF among the individuals excluded from the present study was 17% (761 out of 4485).
The overall mortality in participants was significantly lower compared to the non-participants; however, socioeconomic structure and prevalence of smoking and obesity has been shown to be comparable with the overall population .
The examinations were performed by trained nurses at the screening center. The subjects underwent measurement of blood pressure and anthropometric measures, completed a self-administered questionnaire and sampling of peripheral venous blood. Height was measured in a standing position with a fixed stadiometer, calibrated in centimeters (cm). Weight was rounded off to the nearest 0.1 kg using a balance-beam scale, with the subjects wearing light clothing and no shoes. BMI was calculated as weight (kg) divided by the square of the height (m2). Waist was measured as the circumference (cm) between the lowest rib and the iliac crest. Hip circumference (cm) was measured as the largest circumference between waist and thighs. WHR was defined as the waist circumference divided by the hip circumference. WHtR was defined as the waist circumference divided by the height.
Bioelectric Impedance Analyzers were used (BIA) for estimating body composition, and BF % was calculated using a mathematical algorithm, according to the procedure provided by the manufacturer (BIA 103, RJL systems, single-frequency analyzer, Detroit, USA).
Data on use of lipid-lowering, antihypertensive and anti-diabetic medications, smoking habits, alcohol consumption, leisure-time physical activity, education level, civil status and immigrant status was obtained through a self-admitted questionnaire.
Blood pressure was measured using a mercury-column sphygmomanometer after 10 min of rest in a supine position. Leukocyte concentration was analyzed consecutively in fresh heparinized blood. Diabetes mellitus was defined as self-reported physician’s diagnosis of diabetes or use of anti-diabetic medications or a diagnosis of diabetes in local or national patient registers. Low leisure-time physical activity was defined as the lowest third of a score calculated from 18 questions on physical activity in four seasons.
Subjects were categorized into smokers (occasional or habitual) and non-smokers (ex-smokers and never-smokers). High alcohol consumption was defined as > 40 g per day for men and > 30 g per day for women. Educational level was divided into three categories: < 9 years (primary education), 9–12 years (some/completed secondary education) and > 12 years (education at college or university level). Civil status was categorized into married and not married. Immigration was classified as Swedish-born and foreign born.
Ascertainment of AF
All subjects were followed from the baseline examination until first diagnosis of AF, death, emigration or 31st December 2016, whichever came first. Patients were followed by data linkage with the Swedish Hospital Discharge Register (HDR), the Swedish hospital-based out-patient register and the Swedish Cause of Death Register (CDR), which are administered by the Swedish National Board of Health and Welfare. These registers include all residents of Sweden, and there was no missing data at the stage of data linkage. Malmö University Hospital has reported to the HDR since 1969 and outpatient diagnoses have been reported since 2001. The CDR contains diagnoses from death certificates since 1952.
AF was defined as diagnosis code 427.92 (ICD-8, used up to 1986), 427D (ICD-9, used between 1987 and 1996) and I48 (ICD-10, used 1997–2016) . AF was defined as atrial fibrillation or atrial flutter, since these conditions have a close relationship .
Cox proportional hazards regression was used to examine the association between anthropometric measurements and incidence of AF. The anthropometric measurements used were BMI, WC, WHR, WHtR, BF %, weight and height, which were divided into quartiles with sex-specific quartile limits.
In a second analysis, BMI and WC were divided into commonly used risk-groups. For BMI, “underweight” was defined as BMI < 18.5 kg/m2, “normal weight” as 18.5 ≤ BMI < 25, “overweight” as 25 ≤ BMI < 30, “obese “ as 30 ≤ BMI < 35 and “severe obesity “ as BMI ≥ 35 in both sexes. For WC “Normal” was defined as WC < 94 cm in men and WC < 80 cm in women, “overweight” as 94 ≤ WC < 102 in men and 80 ≤ WC < 88 in women and “obese” as WC ≥ 102 cm in men and WC ≥ 88 cm in women.
The time axis was follow-up time until death, incident AF, emigration from Sweden, or end of follow-up (December 31st, 2016). Hazard ratios (HR) were calculated with 95% confidence intervals (CI). Analyses were performed using three models. The first model adjusted for age. The second model additionally adjusted for and biological risk factors (systolic blood pressure, leukocyte counts, use of antihypertensive and/or lipid-lowering drugs, diabetes mellitus, Apo A1, Apo B, smoking and physical activity). Finally, a third model also included socioeconomic factors (marital status, immigration status, high alcohol consumption and education). Since AF could be secondary to heart failure (HF) or acute myocardial infarction (AMI), we also performed a sensitivity analysis of incident AF in cases without preceding AMI or HF. In this analysis, all individuals were followed until death, incident AF, first diagnosis of heart failure (HF, ICD-10 code I50) or myocardial infarction (AMI ICD-10 code I21-22), date of emigration or December 31st, 2016, whichever came first. In this analysis, those with HF or AMI before baseline examination were excluded.
The proportional hazards assumption was assessed visually using Kaplan–Meier graphs, and found to be valid. Interaction between anthropometric measures and age were examined using multiplicative interaction terms.
To evaluate model discrimination for different anthropometric measures, we calculated Harrell’s c-statistics for the anthropometric measures, with risk factor adjustments in the third model . Since BMI is the most widely used measure of overall obesity, we used BMI as reference and present change of C-statistics (ΔC-statistics) when other anthropometric measures are applied. SPSS version 25 (SPSS Inc., Chicago, IL, USA) and STATA (version 12. StataCorp LLC, TX, USA) were used for statistical analyses.
The characteristics of the final study population are presented in Table 1. Compared to women, men had higher mean values in all anthropometric measurements except for BF %. Men had higher prevalence of hypertension, smoking, diabetes, being married and had lower education compared to women. 2102 out of 9883 men and 2215 out of 16,078 women developed AF. The incidence was 11.8 (per 1000/person-years) for men and 6.98 (per 1000/person-years) for women. Mean follow up time was 18 ± 6.5 years for men and 19.7 ± 5.3 years for women.
Baseline characteristics—divided by gender—are presented for quartiles of BMI and WC in Additional file 1: Tables S1-S2.
Risk of developing AF in relation to anthropometric measures
High values of BMI, WC, WHR, WHtR, BF %, weight or height were all associated with an increased risk for developing AF in both sexes, in all three models (Table 2a, b).
The incidence of AF, measured as incidence per thousand person-years increased from the first quartile to the fourth quartile for all anthropometric measures in both men and women (Table 2a, b). Kaplan–Meier graphs are presented in Additional file 1: Figure S3A-G and S4A-G.
The HRs of incident AF in men (fourth vs. first quartile) were 1.62 for BMI, 1.67 for WC, 1.30 for WHR, 1.37 for WHtR, 1.21 for BF %, 2.02 for weight and 1.67 for height, with adjustments in the third model. For women, the HRs of incident AF were 1.52 for BMI, 1.63 for WC, 1.24 for WHR, 1.39 for WHtR, 1.45 for BF %, 1.93 for weight and 1.92 for height. All HRs were significant, with p-values (first vs. fourth quartile) ≤ 0.001. P-values for trends across quartiles were also statistically significant (p ≤ 0.002). The results are presented graphically in Fig. 1a, b.
There were no significant interactions between anthropometric measures and age in men (p > 0.38). However, in women there were significant interactions between age and weight (p for interaction < 0.01), BMI (p = 0.03) and BF % (p < 0.01), respectively, indicating stronger effects of obesity in younger women (below median age 57 years) compared to older women (> 57 years).
Incidence of AF in relation to commonly used cut-offs for BMI and WC are shown in Additional file 1: Figure S5A-B.
C-statistics for weight were significantly higher than for BMI in men and women. C-statistics for WHR, WHtR and BF % was significantly lower than for BMI in men and women (Table 3).
A sensitivity analysis was performed wherein individuals with incident AMI or HF were followed until the date of AMI or HF diagnosis, and censored after that. A total of 3099 cases of incident AF (1439 men and 1660 women) remained in this analysis. The adjusted HR for incident AF in men, without preceding AMI or HF, were (fourth vs. first quartile) 1.76 for BMI, 1.74 for WC, 1.34 for WHR, 1.44 for WHtR, 1.20 for BF %, 2.02 for weight and 1.53 for height. For women, the corresponding HRs were 1.47 for BMI, 1.58 for WC, 1.30 for WHR, 1.35 for WHtR, 1.46 for BF %, 1.91 for weight and 1.94 for height (Additional file 1: Table S6A and B).
To summarize the results, all anthropometric measures were positively associated with an increased risk for developing AF. The effect was higher for BMI and weight compared to WHR and BF %, and weight showed the best model discrimination of all anthropometric measures. The incidence of AF was highest in the fourth quartile of each anthropometric measure in both men and women.
Obesity has previously been associated with higher risk of developing AF [4, 5, 7,8,9, 12, 20], and high BMI, height, weight, WC and BF % have all been associated with an increased risk of AF [9, 20, 27,28,29]. This study confirms the association between obesity and the risk of developing AF. BMI, height, weight, WC, WHR, WHtR and BF % were all risk factors for AF, supporting the results from a similar Danish cohort study . However, HRs comparing the 4th versus 1st quartiles of anthropometric measures indicated that overall weight (e.g. BMI and weight) was more predictive than measures of abdominal obesity (e.g. WHR and WHtR).
Our data suggests that weight is a slightly better predictor of AF than BMI, which is better than BF %, WHR and WHtR in both men and women. Weight and height are correlated, and both have independently been associated with increased risk of AF . This could explain why weight was a slightly better predictor than BMI.
Although the underlying biological mechanism is uncertain, it has been shown that obesity is associated with increased heart volume—especially left atrial volume—which has been proved a precursor for AF . Additionally, tall non-obese individuals have bigger hearts and increased risk of AF and some studies show that height itself could be a risk factor for AF . It is thought that increased left atrial volume is correlated with increased number of cardiomyocytes in the pulmonary sleeves, triggering AF. As previously mentioned, obesity is also associated with increased pericardial tissue, which is a risk for structural changes within the heart that alter the cardiac electrical circuits, causing AF . In addition, obesity–related hypertension as well as various obesity-related hormones, such as leptin, adiponectin and tumor necrosis factor α  could also be common links between obesity, cardiac remodeling and increased risk of AF .
Due to the increasing prevalence of obesity [10, 33], the occurrence, morbidity and mortality of AF is expected to increase globally. Hence, it is important to understand which anthropometric measures that can be used to evaluate the individual risk for AF. For some diseases, e. g. diabetes, it has been shown that abdominal adiposity is a strong risk factor, and that fat distribution is of great importance [4, 34]. In contrast, the results of this study suggest that overall obesity is more important than abdominal obesity for the risk of developing AF.
Obesity is also a well-documented risk factor for hypertension and diabetes . Although we adjusted for hypertension and diabetes at the baseline examination, it was not possible to adjust for these risk factors during the follow-up period. It is therefore still possible that incidence of hypertension and diabetes could contribute to the increased risk of AF in obese individuals. Further, obesity is also a risk factor for other conditions associated with AF, such as obstructive sleep apnea, heart failure and myocardial infarction, all of which are risk factors for AF. However, our analysis were essentially unchanged when we analyzed AF without prior myocardial infarction or heart failure in a sensitivity analysis. These factors could also be regarded as parts of the causal chain between obesity and AF. Additionally, some studies suggest that weight reduction can decrease the cardiac volume and the burden of symptoms, namely the frequency and duration of AF episodes in patients with AF , suggesting that weight control can be of value with manifest AF as well.
This study has several strengths: it is a population-based study, with a large number of participants that have been followed for more than 16–18 years. The case validity for AF-diagnosis in the MDC-cohort has been shown to be high . The patients have been followed by linkage with the Swedish patient registers. However, AF is sometimes subclinical and undetected, and we cannot rule out that some cases have been missed, but since most individuals in this age-group visit a doctor at some time-point it is likely that most cases will be identified by the registers. The relatively high cumulative incidence of AF in the study (16.6%) supports this view.
Participants with incident AF were on average less healthy than those without AF and residual confounding is always a potential cause of bias in observational studies. Although several baseline characteristics have been adjusted for there are still potential confounders, such as thyroid disease or pulmonary diseases, that have not been adjusted for. This is a limitation to this study.
Another possible limitation in this study is that obese individuals are more prone to seek medical care, due to co-morbid conditions, than non-obese individuals. This might result in more cases of diagnosed AF in the obese population than in the non-obese population. However, our results are in accordance to those from other studies on the subject [9, 20]. Another limitation is that no ECG were taken at the baseline examination and that some individuals could have had subclinical and undetected AF. However, prevalence of AF is low in this age-group (mean 58 years) and it can be assumed that the number of undetected cases of AF is small.
The group of incident AF consists of several subgroups, such as paroxysmal AF, persistent AF and atrial flutter, which have not been analyzed separately. This must be taken into consideration, since these subtypes theoretically could have different relationships with anthropometric measures.
The results of this study indicate that an increase in weight, height, BMI, WC, WHR, WHtR and BF % all increase the risk of AF in both sexes, confirming previous results from similar studies. In contrast to several other cardiometabolic diseases, where abdominal obesity is associated with a higher risk, weight and general obesity seems to be more important than abdominal obesity as a risk factor for developing AF.
Availability of data and materials
The data that support the findings of this study are available from “The Malmö Cohorts” at Lund’s University (https://www.malmo-kohorter.lu.se/malmo-cohorts) upon reasonable request and with permission of the steering committee.
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898–918.
Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke. 2008;39(12):3145–51.
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894: 1–253.
Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.
Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471–7.
Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57(17):1745–51.
Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–69.
Karas MG, Yee LM, Biggs ML, Djoussé L, Mukamal KJ, Ix JH, et al. Measures of body size and composition and risk of incident atrial fibrillation in older people: the cardiovascular health study. Am J Epidemiol. 2016;183(11):998–1007.
Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005;118(5):489–95.
Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: latest trends. Curr Obes Rep. 2018;7(4):276–88.
Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176–85.
Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose–response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:181–92.
Alpert MA, Omran J, Bostick BP. Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep. 2016;5(4):424–34.
Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022–35.
Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res. 2014;164(4):345–56.
Goudis CA, Korantzopoulos P, Ntalas IV, Kallergis EM, Ketikoglou DG. Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links. J Cardiol. 2015;66(5):361–9.
Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, et al. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab. 2010;95(4):1777–85.
Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–9.
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105–20.
Frost L, Benjamin EJ, Fenger-Gron M, Pedersen A, Tjonneland A, Overvad K. Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter A Danish cohort study. Obesity (Silver Spring). 2014;22(6):1546–52.
Fenger-Grøn M, Overvad K, Tjønneland A, Frost L. Lean body mass is the predominant anthropometric risk factor for atrial fibrillation. J Am Coll Cardiol. 2017;69(20):2488–97.
Berglund GES, Janzon L, Larsson SA. The Malmo Diet and cancer study, design and feasibility. J Intern Med. 1993;1993(233):45–51.
Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001;10(6):489–99.
Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25(2):95–102.
Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter: mechanisms and clinical implications. J Am Coll Cardiol. 2008;51(8):779–86.
Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–87.
Chamberlain AM, Agarwal SK, Ambrose M, Folsom AR, Soliman EZ, Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010;159(5):850–6.
Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O’Hara G, et al. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J. 2009;30(10):1270–8.
Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J. 2009;30(9):1113–20.
Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105:1860–7.
Anaszewicz M, Wawrzeńczyk A, Czerniak B, Banaś W, Socha E, Lis K, et al. Leptin, adiponectin, tumor necrosis factor α, and irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular diseases. Kardiol Pol. 2019;77(11):1055–61.
Kamareddine L, Ghantous CM, Allouch S, Al-Ashmar SA, Anlar G, Kannan S, et al. Between inflammation and autophagy: the role of leptin-adiponectin axis in cardiac remodeling. J Inflamm Res. 2021;14:5349–65.
Flodmark CE. Prevention models of childhood obesity in Sweden. Obes Facts. 2018;11(3):257–62.
Borné Y, Nilsson PM, Melander O, Hedblad B, Engström G. Multiple anthropometric measures in relation to incidence of diabetes: a Swedish population-based cohort study. Eur J Public Health. 2015;25(6):1100–5.
Open access funding provided by Lund University. The Swedish Heart–Lung foundation (GE, LJ) and Infrastructure grants from Lund University “Malmö population-based cohorts” (STYR 2019/2046) supported the study.
Ethics approval and consent to participate
The research project has been performed in accordance with the Declaration of Helsinki. The ethics committee at Lund’s University, Lund, approved the study (LU 51/90), and all participants provided written informed consent, with the purpose of studying risk factors for CVDs and other chronic conditions. Ethical approval has been obtained to perform the physical examinations in between 1991 and 1996. Ethical approval has also been obtained to follow-up patients using the HDR and the CDR-registers. This study meets the purpose of the initial purpose with the study, since it investigates risk factor for AF, which is one of the major CVDs. This project did not put individuals at any medical risk, since no new examinations were performed, but only analysis of already existing data. However, data about health in individuals is sensitive information since it risks of putting individual integrity at risk. In this study, each analysis was performed on unidentifiable data, where each subject was coded. Only password protected computers were used. Both these actions minimize the risk of compromising on the integrity of any individual. All data is presented on group level. No single study-participant will be identifiable. Since AF is a major risk factor for stroke, heart failure and mortality, and since AF is a preventable and potentially reversible condition, we conclude that the risks with this study were minimal and that potential gained knowledge outweigh these risks. All individuals have given consent to their data being used in this kind of research projects.
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zia, I., Johnson, L., Memarian, E. et al. Anthropometric measures and the risk of developing atrial fibrillation: a Swedish Cohort Study. BMC Cardiovasc Disord 21, 602 (2021). https://doi.org/10.1186/s12872-021-02415-6
- Atrial fibrillation
- Hazards ratio
- Anthropometric measures